After hospital posts around the West Country, I joined the Peninsula Medical School in 2006 for a laboratory project and clinical trials of cannabis in multiple sclerosis (MS). As a Clinical Research Fellow, I have since been involved in many other MS studies, along with several for Alzheimer's and Parkinson's disease. My interest is in understanding the mechanisms of neurodegeneration while enjoying the region's great outdoors (such as Corndon Tor, photo).
Qualifications
MRCP Member of the Royal College of Physicians, London (2005)
MSc (Commendation) Molecular Neuroscience, University of Bristol (2000)
MB ChB Bachelor of Medicine, Bachelor of Surgery, University of Bristol (1997)
Professional membership
General Medical Council (No. 4422064)
Teaching
Teaching interests
I provide three annual plenaries for first and second year medical students:
Cranial Nerves
Multiple Sclerosis: An Overview
Nervous System Revisited
Publications
Hosking R & Zajicek J (2014) Pharmacology: Cannabis in neurology – a potted review. Nature Reviews Neurology 10(8) 429-430
Hosking RD & Zajicek JP (2008) Therapeutic potential of cannabis in pain medicine. British Journal of Anaesthesia 101(1) 59-68
Mahoney SA, Hosking R & Wynick D (2003) The galanin antagonist M35 has intrinsic agonistic activity in the dorsal root ganglion. Neuroreport 14(12) 1649-1652
Mahoney SA, Hosking R, Farrant S. et al. (2003) The second galanin receptor GalR2 plays a key role in neurite outgrowth from adult sensory neurons. Journal of Neuroscience 23(2) 416-421
What do results from the Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial tell us about the potential of cannabinoids for neuroprotection?
22nd Annual Symposium, International Cannabinoid Research Society, Freiburg, Germany 2012
Cannabinoid influence on primary human monocyte activation and isolation of human microglia
18th Annual Symposium, International Cannabinoid Research Society, Aviemore, Scotland 2008